Product Information
POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID is a generic product labeled by Endo USA Inc., priced at $0.0562 per ML under NDC 00603154358. Its NADAC has been published 572 times since Jul 15, 2015.
Strength
40 meq/15mL
Manufacturer
Endo USA Inc.NDC
00603154358
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA206814On Market Since
5/4/2015
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has been published 572 times since Jul 15, 2015, and over the history we have for it it has declined 51.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0562 per ML |
|---|---|
| All-time high | $0.9714 (Nov 16, 2016) |
| All-time low | $0.0440 (Dec 17, 2025) |
| 52-week high | $0.0677 |
| 52-week low | $0.0440 |
| Median price | $0.5063 |
| Average price | $0.4674 |
| Largest weekly change | +199.3% (Oct 21, 2015) |
| Weeks tracked | 572 |
| Tracking since | Jul 15, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Potassium Chloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID, manufactured by Endo USA Inc., is $0.0562 per ML (NDC 00603154358), effective Jun 24, 2026.
How has the price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID changed over time?
Over the history we have for it, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has declined 51.3%. It has been tracked across 572 weekly CMS publications since Jul 15, 2015.
What are the highest and lowest recorded NADAC prices for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
Since Jul 15, 2015, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has ranged from a low of $0.0440 (Dec 17, 2025) to a high of $0.9714 (Nov 16, 2016), with a median of $0.5063 per ML.
Are there cheaper alternatives to POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID, so no direct lower-cost alternative is listed.
Who manufactures POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID (NDC 00603154358) is labeled by Endo USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification